HPS/PayMedix has secured $33 million in equity and debt financing to enhance its healthcare financing and payment solutions platform, driven by rising demand for affordable access to healthcare.
Target Information
HPS/PayMedix is a prominent provider of healthcare financing and payment solutions, specializing in simplifying the payment experience for all stakeholders involved in healthcare. The company has developed the innovative PayMedix platform, which facilitates guaranteed payments to providers and offers interest-free financing options for consumers. Since its inception, PayMedix has successfully processed over $7 billion in medical payments, leading to significant enhancements in how individuals access and pay for healthcare services.
In 2024, PayMedix expanded its service offerings by acquiring TempoPay, further enhancing its financing solutions to cover additional healthcare expenses, including pharmacy, dental, and vision services. The company boasts a remarkable track record, with high retention rates among providers (100%) and employers (over 93%), as well as impressive consumer satisfaction ratings exceeding 91%.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the United States
The healthcare industry in the United States is experiencing transformative changes, primarily driven by the urgent need for affordable access to medical services amid rising costs. As employers, providers, and payors increasingly seek alternative fina
Similar Deals
Five Arrows → Blue Mountain
2026
Gryphon Investors → Fortreum
2026
Wavecrest Growth Partners and Radian Capital → Dealerware
2026
TA Associates → PairSoft
2026
DTCP Growth → Groq
2025
Baird Capital → EvoluteIQ
2025
HLM Investment Partners
invested in
HPS/PayMedix
in 2026
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $33M
Equity Value: $16M